FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely oncology and concerns treating lung cancer. That is ensured by 6 therapeutic sessions every 21 day according to the scheme: the patient is exposed to hyperbaric oxygenation at pressure 1.3 atm, 30 min daily for 5 days; and then chemotherapeutic preparations are administered as follows: on the 6th day, kemoplat dissolved in 0.9% sodium chloride is administered in a dose of 75 mg/m2 of the patient's body; on the 6th, 8th and 10th days, phytoside 120 mg/m2 of the patient's body dissolved in 0.9% sodium chloride is administered.
EFFECT: dose schedule of the chemopreparations in a combination with the hyperbaric oxygenation provides reducing such side effects of the chemotherapy as leukopenia and anaemia that in turn enables the following sessions of chemotherapy in the prescribed time and thereby increasing the clinical effectiveness in lung cancer.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING ONCOLOGICAL PATIENTS WITH LUNG CANCER | 2011 |
|
RU2481091C1 |
METHOD OF TREATMENT OF INOPERABLE SQUAMOUS CELL CARCINOMA OF HEAD AND NECK | 2023 |
|
RU2806512C1 |
METHOD FOR TREATING MALIGNANT TUMORS OF PENIS | 1996 |
|
RU2139113C1 |
METHOD OF INHIBITING TUMOUR GROWTH IN MAMMAL | 2018 |
|
RU2713153C1 |
METHOD OF ORGAN-PRESERVING TREATMENT OF SQUAMOUS CELL CARCINOMA OF ORAL MUCOSA cT1N0M0 WITH DEPTH OF TUMOUR INVASION UP TO 5 mm | 2023 |
|
RU2824427C2 |
METHOD OF LUNG CANCER TREATMENT | 2014 |
|
RU2554750C1 |
METHOD FOR TREATMENT OF PATIENTS WITH GASTRIC CANCER WITH LIMITED PERITONEAL CARCINOMATOSIS | 2021 |
|
RU2769493C2 |
METHOD OF TREATING METASTATIC INJURY OF BRAIN | 2014 |
|
RU2547082C1 |
METHOD OF TREATING PATIENTS WITH PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM | 2024 |
|
RU2831407C1 |
IMMUNOMODULATING PREPARATION "BETALEUKIN" | 1998 |
|
RU2128706C1 |
Authors
Dates
2013-08-27—Published
2011-11-15—Filed